GlaxoSmithKline (LSE & NYSE: GSK) and POZEN Inc. (NASDAQ: POZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for Trexima? (sumatriptan/naproxen sodium). An approvable letter is an official notification from the FDA that contains conditions that must be satisfied prior to obtaining final U.S.marketing approval.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Adolescents from low-income families are much more likely to suffer from migraine headaches than teens from wealthier households, according to researchers at the Albert Einstein College of Medicine of Yeshiva University. The findings, published in Neurology, suggest that factors associated with low socioeconomic status –stress, poor diet and limited access to medical care, for example — increase the prevalence of migraines in young people.Led by Dr.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Teenagers from low income households with no family history of migraine are more likely to suffer migraine than children from upper income families, according to a study published in the July 3, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers surveyed 18,714 adolescents and their parents. A total of 1,178 adolescents had migraine.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Results from a new study presented at the 13th Congress of the International Headache Society (IHC) today show that zolmitriptan (’Zomig’) 10mg nasal spray provides rapid relief from the excruciating pain of cluster headache, a condition recognised as one of the most painful known to mankind, at 10 minutes vs. placebo.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Migraines and chronic headaches are wide-spread phenomena. Twelve percent of the population, three quarters of them women, suffer at least occasionally from migraines and about 5 percent from chronic headaches. New effective methods of treatment were presented at the Congress of the European Neurological Society (ENS) in Rhodos.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Tension headaches are very common and are most likely in adults and adolescents. A tension headache is where there is muscle tightness in certain areas in the head, scalp or neck accompanied by pain or discomfort in the same place. The symptoms are a dull, all-over-pain which often feels like a tight band or vice on the head. Such headaches are caused by the tension in the neck and scalp muscles and may be as a result of stress, depression, head injury or anxiety.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
According to preliminary results of an ongoing study at Columbus Children’s Hospital, to be presented at the American Headache Society’s June meeting in Chicago, parents of adolescents with migraines may have an influence on the level of pain reported. Approximately 10 percent of children and adolescents get migraines, and as many as two percent suffer from chronic migraines, meaning 15 or more headaches a month.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
New data from two large trials show that Trexima, when taken early, was nearly twice as effective as placebo in eliminating all traditional migraine symptoms at two and four hours across multiple attacks with just one tablet. The findings will be presented tomorrow at the 49th Annual Scientific Meeting of the American Headache Society.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
There are more than two million kids who suffer from migraines in this country - some as young as five years old.* Nearly 9 times out of 10, those kids come from families with a history of migraines.* While these headaches may be shared, does that mean the pain is necessarily the same? A new study is underway to find out how much pain is genetic, and how much is mimicked. Shaina Malo has learned that it’s best to do her homework as soon as she gets home from school.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
MAP Pharmaceuticals, Inc. today announced that it will present Phase 2 data from its MAP0004 migraine therapy clinical program at the 49th Annual American Headache Society Meeting at the Hyatt Regency Chicago in Chicago, Illinois.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...